NSAIDs May Not Lower Lung Cancer Risk in Postmenopausal Women

Share this content:

the Cancer Therapy Advisor take:

No statistically significant association was found between nonsteroidal anti-inflammatory drugs (NSAID) and lung cancer risk in postmenopausal women even after adjustments were made for female-specific confounders, according to an article published online in the journal Cancer Epidemiology, Biomarkers & Prevention.

Prospective studies suggest that NSAID use may decrease lung cancer risk in men.  However, this specific study focused on NSAID’s relationship to lung cancer risk in women.  In the study, 143,841 women between the ages of 50 to 79 were identified and 1,902 of the women confirmed lung cancer cases in the analysis.  Any potential female-specific confounders, such as hormone therapy and smoking histories, were adjusted for.

Results concluded that nonuse compared to regular NSAID use was not associated with overall lung cancer incidence (NSAID use >10 years HR=0.87; 95% CI: 0.71, 1.08; Ptrend=0.13).  A trend of decreased risk with longer duration of NSAID use was observed in the adenocarcinoma subtype, but it was not statistically significant (NSAID use >10 years HR=0.80; 95% CI: 0.58, 1.10; Ptrend=0.07).

The study suggests that future studies examine the various molecular subtypes of non-small cell lung cancer to further explore possible relationships between NSAIDs and lung cancer, especially for the adenocarcinoma subtype.

Brisk Walking May Cut Breast Cancer in Black Women
No significant association found between nonsteroidal anti-inflammatory drugs and lung cancer risk in postmenopausal women.
Results from prospective studies suggest that nonsteroidal anti-inflammatory drugs (NSAID) may decrease lung cancer risk; however, any protective effect appears to be most evident in men.
READ FULL ARTICLE From cebp.aacrjournals.org

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters